Dr. Michael Dickinson | ICML 2017 | Tazemetostat in FL and DLBCL

Tazemetostat in FL and DLBCL

Prof. Hervé Tilly | ICML 2017 | POLA-R-CHP in treatment naïve DLBCL

Prof. Hervé Tilly, from CRLCC Henri Becquerel, Rouen, FR, on POLA-R-CHP in treatment naïve DLBCL

Prof. Hervé Tilly | ICML 2017 | POLA-R-CHP in treatment naïve DLBCL

Prof. Hervé Tilly, from CRLCC Henri Becquerel, Rouen, FR, on POLA-R-CHP in treatment naïve DLBCL

Prof. Stephen J. Schuster | ICML 2017 | Interim results of the JULIET trial of CTL019 in R/R DLBCL

Prof. Stephen J. Schuster, from the Abramson Cancer Center, Philadelphia, PA, US, on interim results from the phase II JULIET study

Prof. Stephen J. Schuster | ICML 2017 | Interim results of the JULIET trial of CTL019 in R/R DLBCL

Prof. Stephen J. Schuster, from the Abramson Cancer Center, Philadelphia, PA, US, on interim results...

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month

First Name

Last Name

I agree to the Lymphoma Hub Terms & Conditions